Feng J. Jiao
No. 160 Pujian Road
Shanghai, 200127, China
Shanghai, 200127, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Surufatinib plus paclitaxel as second-line therapy for advanced gastric cancer: a single-arm, phase 2 clinical trial.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: May 06, 2025
A weakly supervised deep learning framework for automated PD-L1 expression analysis in lung cancer.
Journal: Frontiers in immunology
Published: December 05, 2024
ImmunoPET imaging of Trop2 in patients with solid tumours.
Journal: EMBO molecular medicine
Published: December 31, 2023
Detection of ROS1 gene fusions using next-generation sequencing for patients with malignancy in China.
Journal: Frontiers in cell and developmental biology
Published: September 02, 2022
Identification of BIK as an unfavorable prognostic marker and novel therapeutic target in microsatellite stable colorectal cancer harboring KRAS mutations.
Journal: American journal of cancer research
Published: August 03, 2022
Distinguishable Prognostic Signatures and Tumor Immunogenicity Between Pancreatic Head Cancer and Pancreatic Body/Tail Cancer.
Journal: Frontiers in oncology
Published: March 06, 2022
Clinical Features of Multiple Primary Malignant Tumors: A Retrospective Clinical Analysis of 213 Chinese Patients at Two Centers.
Journal: Discovery medicine
Published: February 27, 2022
Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer.
Journal: Journal of the National Cancer Center
Published: January 04, 2022
Characterization of the genomic landscape in large-scale Chinese patients with pancreatic cancer.
Journal: EBioMedicine
Published: October 13, 2021
Characterization of DNA damage response deficiency in pancreatic cancer patients from China.
Journal: Cancer communications (London, England)
Published: June 14, 2021
Last Updated: 09/26/2026